References
1. Ohga S, Mugishima H, Ohara A, et al. Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation. Int J Hematol. 2004; 79: 22-30.
2. Strahm B, Loewecke F, Niemeyer CM, et al. Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia. Blood Adv. 2020; 4: 1760-1769.
3. Koyamaishi S, Kamio T, Kobayashi A, et al. Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia. Bone Marrow Transplant. 2021; 56: 1013-1020.
4. Asquith JM, Copacia J, Mogul MJ, Bajwa RP. Successful use of reduced-intensity conditioning and matched-unrelated hematopoietic stem cell transplant in a child with Diamond-Blackfan anemia and cirrhosis.Pediatr Transplant. 2015; 19: E157-9.
5. Kothari A, Ngwube A, Hayashi R, et al. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin. Biol Blood Marrow Transplant. 2015; 21: 1321-1325.
6. Burroughs LM, Shimamura A, Talano JA, et al. Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. Biol Blood Marrow Transplant. 2017; 23: 1669-1677.
7. Crazzolara R, Kropshofer G, Haas OA, Matthes-Martin S, Kager L. Reduced-intensity conditioning and stem cell transplantation in infants with Diamond Blackfan anemia. Haematologica. 2017; 102: e73-e75.
8. Darrigo LG Junior, Loth G, Kuwahara C, et al. Hematopoietic cell transplantation for Diamond Blackfan anemia: A report from the Pediatric Group of the Brazilian Bone Marrow Transplantation Society. Eur J Haematol. 2020; 105: 426-433.
9. Miano M, Eikema DJ, de la Fuente J, et al. Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplant Cell Ther. 2021; 27: 274.e1-274.e5.
10. Diaz-de-Heredia C, Bresters D, Faulkner L, et al. Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT. Bone Marrow Transplant. 2021; doi: 10.1038/s41409-021-01449-w.2021.
11. Malär R, Sjöö F, Rentsch K, Hassan M, Güngör T. Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipients. Pediatr Transplant. 2011; 15: 580-588.
12. Ottaviano G, Achini-Gutzwiller F, Kalwak K, et al. Impact of in Vivo Lymphodepletion on Outcome in Children with Nonmalignant Disorders Receiving Peripheral Blood Stem Cell Transplantation. Transplant Cell Ther. 2021; S2666-6367: 01165-01169.
13. Law J, Cowan MJ, Dvorak CC, Musick L, Long-Boyle JR, Baxter-Lowe LA, Horn B. Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution. Biol Blood Marrow Transplant. 2012; 18: 1656-1663.
14. Bonfim C. Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes. Hematology Am Soc Hematol Educ Program.2020; 2020(1): 107-114.
15. Chiesa R, Standing JF, Winter R, et al. Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.Clin Pharmacol Ther. 2020; 108: 264-273.
16. Lipton JM, Federman N, Khabbaze Y, Schwartz CL, Hilliard LM, Clark JI, Vlachos A; Diamond-Black Anemia Registry. Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol. 2001; 23: 39-44.
17. Matsuda I, Tsuchida YA, Toyoshima F, et al. Occurrence of colon tumors in a 16-year-old Japanese boy after hematopoietic stem cell transplantation for Diamond Blackfan anemia at age of 4: a case report.Int J Clin Exp Pathol. 2015; 8: 5938-5943.
18. Vlachos A, Rosenberg PS, Atsidaftos E, et al. Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia.Blood. 2018; 132: 2205-2208.
19. Quarello P, Garelli E, Carando A, et al.; AIEOP working group on Diamond Blackfan Anaemia. A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease? Br J Haematol. 2020; 190: 93-104.
20. Kebudi R, Ozger H, Kızılocak H, Bay SB, Bilgiç B. Osteosarcoma After Hematopoietic Stem Cell Transplantation in Children and Adolescents: Case Report and Review of the Literature. Pediatr Blood Cancer.2016; 63: 1664-1666.